MicroRNAs as potential biomarkers in diseases and toxicology

被引:45
|
作者
Siddeek, Benazir [1 ,2 ,6 ]
Inoubli, Lilia [1 ,2 ]
Lakhdari, Nadjem [1 ,2 ]
Rachel, Paul Bellon [1 ,2 ]
Fussell, Karma Claire [7 ]
Schneider, Steffen [7 ]
Mauduit, Claire [1 ,2 ,3 ,4 ]
Benahmed, Mohamed [1 ,2 ,5 ]
机构
[1] INSERM, U1065, Ctr Mediterraneen Med Mol C3M, Team 5, F-06204 Nice, France
[2] Univ Nice Sophia Antipolis, UFR Med, F-06000 Nice, France
[3] Univ Lyon 1, UFR Med Lyon Sud, F-69921 Lyon, France
[4] Hosp Civils Lyon, Hop Lyon Sud, Lab Anat & Cytol Pathol, F-69495 Pierre Benite, France
[5] CHU Nice, Pole Digestif, Ctr Reprod, F-06202 Nice, France
[6] BASF Agro, F-69130 Ecully, France
[7] BASF SE, Expt Toxicol & Ecol, D-67056 Ludwigshafen, Germany
关键词
MicroRNAs; Chemicals; Circulating biomarkers; ESTROGEN-RECEPTOR-ALPHA; BLOOD-BASED MARKERS; CIRCULATING MICRORNAS; GENE-EXPRESSION; DOWN-REGULATION; MIRNA EXPRESSION; PANCREATIC ADENOCARCINOMA; MICROARRAY ANALYSIS; COLORECTAL-CANCER; HUMAN SPERMATOZOA;
D O I
10.1016/j.mrgentox.2014.01.010
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
MiRNAs (microRNAs) are single-stranded non-coding RNAs of approximately 21-23 nucleotides in length whose main function is to inhibit gene expression by interfering with mRNA processes. MicroRNAs suppress gene expression by affecting mRNA (messenger RNAs) stability, targeting the mRNA for degradation, or both. In this review, we have examined how microRNA expression could be altered following exposure to chemicals and how they could represent appropriate tissue and more interestingly circulating biomarkers. Among the key questions before using the microRNA for evaluation of risk toxicity, it remains still to clarify how they could be causally involved in the adverse effects and how stable their changes are. (C) 2014 Published by Elsevier B.V.
引用
收藏
页码:46 / 57
页数:12
相关论文
共 50 条
  • [41] microRNAs regulation and its role as biomarkers in diseases
    Huandi Zhou
    Xiaohui Ge
    Xiaoying Xue
    Oncology and Translational Medicine, 2016, 2 (01) : 39 - 46
  • [42] Circulating microRNAs as biomarkers in pediatric heart diseases
    Sucharov, Carmen C.
    Miyamoto, Shelley D.
    Garcia, Anastacia M.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2018, 49 : 50 - 52
  • [43] MicroRNAs and Diseases: Promising Biomarkers for Diagnosis and Therapeutics
    Dwivedi, Shailendra
    Purohit, Purvi
    Sharma, Praveen
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2019, 34 (03) : 243 - 245
  • [44] Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases
    Tijsen, Anke J.
    Pinto, Yigal M.
    Creemers, Esther E.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 303 (09): : H1085 - H1095
  • [45] Circulating microRNAs: novel biomarkers for cardiovascular diseases
    Jiahong Xu
    Jiangmin Zhao
    Graham Evan
    Chunyang Xiao
    Yan Cheng
    Junjie Xiao
    Journal of Molecular Medicine, 2012, 90 : 865 - 875
  • [46] Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases
    Xue-Feng Jin
    Ning Wu
    Lv Wang
    Jin Li
    Cellular and Molecular Neurobiology, 2013, 33 : 601 - 613
  • [47] Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases
    Jin, Xue-Feng
    Wu, Ning
    Wang, Lv
    Li, Jin
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2013, 33 (05) : 601 - 613
  • [48] Biotherapeutic potential of microRNAs in rheumatic diseases
    Yves-Marie Pers
    Christian Jorgensen
    Nature Reviews Rheumatology, 2013, 9 : 76 - 78
  • [49] MicroRNAs in neurodegenerative diseases and their therapeutic potential
    Junn, Eunsung
    Mouradian, M. Maral
    PHARMACOLOGY & THERAPEUTICS, 2012, 133 (02) : 142 - 150
  • [50] Biotherapeutic potential of microRNAs in rheumatic diseases
    Pers, Yves-Marie
    Jorgensen, Christian
    NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (02) : 76 - 78